EyePoint

#药闻简讯# $EyePoint(EYPT)$ 已完成DURAVYU在湿性年龄相关性黄斑变性（wet AMD）的第三阶段患者招募。
LUGANO的关键数据预计将于2026年年中公布，LUCIA的关键数据也将紧随其后。
现金及现金等价物2.56亿美元

$EyePoint(EYPT)$ 治AMD最优？
$再生元制药(REGN)$ eylea近三年近百亿销售额

$EyePoint(EYPT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001193125-25-175418  Act: 34  Size: 9 MB 网页链接

$EyePoint(EYPT)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-25-175479  Act: 33  Size: 760 KB 网页链接

$EyePoint(EYPT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001429932-25-000005  Size: 7 KB 网页链接

$EyePoint(EYPT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-25-103527  Act: 34  Size: 563 KB 网页链接

$EyePoint(EYPT)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0000902664-25-003516  Act: 34  Size: 12 KB 网页链接

$EyePoint(EYPT)$ 8-K/A [Amend] Current report, items 8.01 and 9.01 Accession Number: 0000950170-25-099413  Act: 34  Size: 14 MB 网页链接

$EyePoint(EYPT)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0000950170-25-099383  Act: 34  Size: 14 MB 网页链接